623 results on '"Potepan P"'
Search Results
2. Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study
3. Correction to: Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood
4. Docetaxel, cisplatin and 5-fluorouracil-based induction chemotherapy followed by intensity-modulated radiotherapy concurrent with cisplatin in locally advanced EBV-related nasopharyngeal cancer
5. Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood
6. Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study
7. Long-term results of combined preradiation chemotherapy and age-tailored radiotherapy doses for childhood medulloblastoma
8. A lower-dose, lower-toxicity cisplatin–etoposide regimen for childhood progressive low-grade glioma
9. Clinical and radiological features of brain neurotoxicity caused by antitumor and immunosuppressant treatments
10. Five-day infusion fluorouracil plus vinorelbine in women with breast cancer previously treated with anthracyclines and paclitaxel
11. Multifocal osteosarcoma as second tumor after childhood retinoblastoma
12. Non-small-cell lung cancer: detection of mediastinal lymph node metastases by endoscopic ultrasound and CT
13. A method for dynamic subtraction MR imaging of the liver
14. Do we really need class 1 evidence results to give adjuvant radiation therapy to childhood intracranial ependymomas?
15. Personality Characteristics and Affective Reactions toward Exams of Superior and Failing College Students
16. Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancers
17. Induction chemotherapy with carboplatin/paclitaxel followed by surgery or standard radiotherapy and concurrent daily low-dose cisplatin for locally advanced non-small cell lung cancer (NSCLC)
18. A prospective protocol for nasopharingeal carcinoma in children and adolescents
19. Second-look surgery for ependymoma: the Italian experience
20. Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial
21. Induction chemotherapy within a multimodality treatment of nasal cavity and ethmoid sinus malignant epithelial tumours: report of an homogeneous series of patients
22. CISPLATIN DOSE INTENSITY CORRELATES WITH OUTCOME IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA RECEIVING CONCURRENT CISPLATIN BASED CHEMORADIATION: A MULTI-INSTITUTIONAL EXPERIENCE
23. Sviluppo di un algoritmo di segmentazione EM per la determinazione della volumetria delle neoplasie delle fosse nasali e dei seni paranasali da indagini di risonanza magnetica
24. Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial
25. OC-039: Surveillance of Head and Neck Cancer (HNC) Patients: Clinical and Radiological Exams or Symptom Driven Follow Up?
26. Whole-Body Diffusion MRI and Skeletal Lesions in Thyroid Cancer: Diagnostic and Therapeutic Implications
27. Quantitative characterization and identification of lymph nodes and Nasopharingeal Carcinoma by coregistered magnetic resonance images
28. DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
29. RADIOLOGY
30. 4125 POSTER Nimotuzumab and Vinorelbine Concomitantly to Radiation and as Maintenance for Diffuse Pontine Glioma in Childhood – Promising Results on a Series of 13 Patients
31. LOCALLY ADVANCED NASAL CAVITY AND ETHMOID CARCINOMA: INDUCTION CHEMOTHERAPY FOLLOWED BY MULTIMODAL TREATMENT IN A MONOINSTITUTIONAL SERIES OF PATIENTS
32. Patterns of Failure after Intensity Modulated Radiation Therapy (IMRT) and Chemotherapy for Patients with Nasopharyngeal Carcinoma
33. Pediatrics Clinical Research
34. 8535 Induction chemotherapy within a multimodality treatment of nasal cavity and ethmoid sinus malignant epithelial tumours: report of an homogeneous series of patients
35. TPF induction chemotherapy (CT) followed by concomitant cisplatin/radiotherapy (cCTRT) in locally advanced nasopharyngeal cancer (LANPC)
36. Optimizing the treatment ofnasopharyngeal cancer: Anupdate of the milan experience including IMRT and chemotherapy intensification
37. A Fuzzy-C-Means Cluster ing Algorithm for a Volumetr ic Analysis of Paranasal Sinus and Nasal Cavity Cancer s
38. Cetuximab (C225) in recurrent and/or metastatic salivary gland carcinomas (RMSGCs): A monoinstitutional phase II study
39. Improved Detection of Liver Metastasis by Registration and Subtraction of Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
40. Preoperative treatment with paclitaxel and carboplatin in locally advanced non small cell lung cancer (NSCLC): A phase II trial
41. Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancers.
42. Critical analysis of locoregional failures following intensity-modulated radiotherapy for nasopharyngeal carcinoma.
43. Roentgenographic findings of bone metastases from malignant melanoma
44. Omission of bone scan and skeletal X-ray in primary melanoma staging
45. A prospective protocol for nasopharyngeal carcinoma in children and adolescents: the Italian Rare Tumors in Pediatric Age (TREP) project.
46. 1050P - Whole-Body Diffusion MRI and Skeletal Lesions in Thyroid Cancer: Diagnostic and Therapeutic Implications
47. Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapy
48. Abiraterone and Galeterone, Powerful Tools Against Prostate Cancer: Present and Perspective.
49. Rare Head and Neck Cancers and Pathological Diagnosis Challenges: A Comprehensive Literature Review.
50. Tracheal Tumors: Clinical Practice Guidelines for Palliative Treatment and Follow-Up.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.